<< Back to News

System Formulary Update
Phenylephrine 1% and Ketorolac 0.3% (Omidria) Ophthalmic Solutio
February 5, 2026

Phenylephrine-Ketorolac Injection (Omidria) Formulary Recommendation 

Situation:  

Phenylephrin (1%)-Ketorolac (Omidria) ophthalmic solution was approved for addition to the UNC Health System Formulary with the following restrictions: 

Restricted to outpatient clinic or clinic use only     

Background: 

The following medication was reviewed: phenylephrine 1% and ketorolac 0.3% (Omidria). The committee also agreed to review formulary status following NOPAIN act changes at end of 2027 

Assessment/Recommendation 

Change effective: Tuesday, March 17th